JULUCA 50 mg/25 mg, film-coated tablet 30 tablets
Active ingredients: Rilpivirine hydrochloride, Dolutegravir, Dolutegravir sodium, Rilpivirine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JULUCA 50 mg/25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimés
- Marketing authorisation holder
- VIIV HEALTHCARE (PAYS-BAS)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Oct 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63504750CIP73014482CIP133400930144824Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RILPIVIRINEcomprimé | 25 mg · un comprimé | FT |
| DOLUTÉGRAVIR SODIQUEcomprimé | — | SA |
| DOLUTÉGRAVIRcomprimé | 50 mg · un comprimé | FT |
| CHLORHYDRATE DE RILPIVIRINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.